Views Navigation

Event Views Navigation

Today

Suicide and Opioids: Intersections and Opportunities for Prevention

Register Now Presenter: Ellyson Stout, MS, US Director of Community Suicide Prevention, Education Development Center (EDC) Sponsor: National Council for Mental Wellbeing--NCMW   Target Audience: This activity is designed for mental health and addiction treatment professionals, integrated care providers, and medical staff. This activity is accredited for nurses, physicians, physician assistants, social workers, pharmacists, interprofessional […]

Utilizing Passively Collected Data in Daily Life to Enhance the Assessment and Treatment of Mental Health

Register via Zoom Dr. Nick Jacobson is a tenure-track assistant professor in the departments of Biomedical Data Science and Psychiatry within the Center for Technology and Behavioral Health in the Geisel School of Medicine at Dartmouth College. He directs the AI and Mental Health: Innovation in Technology Guided Healthcare (AIM HIGH) Laboratory. Dr. Jacobson researches […]

Recommendations for Culturally Recentering Reinforcement-Based Substance Use Disorder Interventions in Collaboration with Rural Tribal Communities

This presentation will cover ways to culturally adapt and implement contingency management among rural American Indian and Alaska Native communities. This will be achieved by describing evidence around substance use disorder (SUD) in rural American Indian and Alaska Native communities, discussing the importance of cultural adaptation for SUD treatment among members of rural Tribal communities, […]

Tobacco Regulations Across the Continuum of Harm

Tracy Smith, PhD Assistant Professor of Psychiatry and Behavioral Services Medical University of South Carolina   The VCBH Monthly Lecture Series was originally created as an in-person series designed as a way to interact and engage with top researchers in the intersectional fields we often work with at VCBH including behavior change, addiction, chronic disease, […]

Alcohol Use Disorder (FAME Session #3)

Presenters: Abby Letcher, MD, FASAM; Angela Colistra, PhD, LPC, CAADC, CCS; Shanna Diaz, DO Series: This 2-hour, virtual-live session is part of the FAME 8-session series and will cover overdose prevention and harm reduction. The FAME series is a facilitated, in-depth discussion of real patient cases provided by participants with the opportunity to receive mentoring and feedback […]

The Connection Between Mental Health and Opioid Use Disorder

Presenter: Mark Duncan, MD, Assistant Professor, University of Washington, Director, UW Psychiatry and Addictions Case Conference Sponsor: American Psychiatric Association (APA) Cost: No Fee Target audience: Physicians, nurse practitioners or other advanced practice nurses, PAs, social workers, pharmacists, and healthcare teams Credit Designations Available: AAPA Category 1 CME, Social Work CE Credit, Nursing Contact Hours, Pharmacy CE […]

Comparing Methods of Buprenorphine Treatment Initiation in Patients Using Fentanyl

Presenter: Adam Bisaga, MD Target Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. This talk discusses substance use disorder treatment in a post-COVID world. Discussion is designed to promote interactivity through an informal "round table" conversation. Attendees will be given the opportunity to speak directly with the […]

Screening for Substance Use in Primary Care: Screening Tools and Guidance for Implementation

Presenter: Jennifer McNeely, MD Sponsor: American Psychiatric Association (APA) and American Academy of Addiction Psychiatry (AAAP) Cost: No Fee Target audience: Physicians, psychologists, social workers, physician assistants, pharmacists, interprofessional team, residents/fellows, medical students, other mental health clinicians Credit Designations Available: AMA PRA Category 1 Credit™, AAPA Category 1 CME, Social Work CE Credit, Nursing Contact Hours, Pharmacy […]

Illicit Drug Supply: Fentanyl and Xylazine

Presenter: Richard Dawson, PhD, Research Professor at the Vermont Center for Behavior and Health at UVM and a Professor Emeritus at the UCLA Department of Psychiatry This presentation will explore current information about fentanyl and xylazine including: drug supply information, pharmacology, clinical effects, medical impacts, harm reduction and treatment information. Considerations for rural populations will be discussed. Register now! […]

Substance Use Disorders in Late Life

Register Now   Presenters: Roberto D. Sanchez, DO and Ali Abbas Asghar-Ali, MD Target Audience: This activity is designed for Psychiatrists, Physicians, Physician Assistants, Nurses/Nurse Practitioners, Social Workers, Psychologists, Pharmacists, other mental health clinicians working within addiction. This activity is accredited for Physicians, Physician Assistants, Social Workers, Pharmacists, and Healthcare teams. Credit Designations Available: AMA […]

How Adding a Clinical Pharmacist Improves Access to Addiction Care

Register here Presenters: Ben Miskle, PharmD, University of Iowa Hospitals and Clinics Alison Lynch, MD, MS, University of Iowa Hospitals and Clinics Sponsor: American Academy of Addiction Psychiatry (AAAP) Cost: No Fee Target audience: Physicians, nurse practitioners or other advanced practice nurses, PAs, social workers, and pharmacists Credit designations available: Pharmacy CE Credit, AMA PRA Category 1 […]

Nurses’ Practices with People Experiencing Opioid Use Disorder

Register Now   Presenter: Timothy J. Sowicz, PhD, RN Cost: No Fee Target audience: This activity is designed for for Nurses, MAT Team Providers, Addictions Specialists, SUD Project Directors, Managers, and Facilitators. This activity is accredited for nurses. Credit Designations Available: Nursing CE Webinar description: The purpose of this presentation is to present the findings from a narrative literature […]

Co-occurring Opioid and Stimulant Use Disorders: Treatment and Management Approaches

Register Now Presenters: Jonathan Craig Allen, MD, FASAM, and Marc Fishman, MD Sponsor: National Council for Mental Wellbeing--NCMW Continuing education information: AMA PRA Category 1 Credit™, Nursing Contact Hours, AAPA Category 1 CME credit, SW CE credit, Pharmacy CE credit and IPCE credit Target Audience: This activity is designed for physicians, nurses, PAs, pharmacists, social […]

Treatment Considerations in the Age of Fentanyl

Fentanyl and other high-potency synthetic opioids are increasingly present in the U.S. drug supply. Healthcare systems, treatment providers, and justice systems are grappling with the physiological consequences of chronic fentanyl use and how its use may impact treatment. Speakers: - Kathryn Cates-Wessel, CEO, American Academy of Addiction Psychiatry - John J. Mariani, MD, Associate Professor […]

Mindfulness-Oriented Recovery Enhancement: Clinical Outcomes and Biobehavioral Mechanisms of an Evidence-Based Therapy for Chronic Pain, Opioid Misuse, and Opioid Use Disorder

Register Now   Presenter: Eric Garland, PhD, LCSW Sponsoring organization: American Society for Pain Management Nursing (ASPMN) Target audience: Clinical providers including Physicians, PAs and NPs About the webinar: Half of all people with a substance use disorder (SUD) have chronic pain, and more than a third have a co-occurring psychiatric disorder. The ongoing opioid crisis is a […]

Initiating Buprenorphine for Patients Using Fentanyl

Register Now Presenter: Brian Hurley, MD, MBA, DFASAM, FAPA Cost: No Fee Target audience: Nurses, Addictions Specialists, SUD Project Directors, Managers, and Facilitators and MOUD (medications for opioid use disorder) providers Credit Designations Available: Nursing CE Webinar description: This webinar will review variations on buprenorphine dosing that can be considered for patients with opioid use disorder involving fentanyl. The […]

Xylazine and How it Harms People Who Use Drugs

Register now! Presenters: Raagini Jawa, MD Cost: No fee Target Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. Description: We will review what is known to date on Xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US. This […]

Opioid Use Disorder and Social Determinants of Health

Presenters:   Rachel Talley, MD, Assistant Professor of Clinical Psychiatry/Director, Fellowship in Public and Community Psychiatry Jessica Isom, MD, Attending Psychiatrist, Codman Square Health Center/Clinical Instructor, Yale University/Faculty Lead, Social Justice and Health Equity Curriculum Sponsor: National Council for Mental Wellbeing--NCMW Continuing education information: Council for Mental Wellbeing will not be providing Continuing Medical Education […]

Changing the Default: Moving to an Opt-Out Approach for Treating Tobacco Use Disorders

Join us on Wednesday, May 17th for the #VCBHLectureSeries as we welcome Kimber Richter, PhD, MPH, Professor of Population Health at the University of Kansas Medical Center. Dr. Richter will present "Changing the Default: Moving to an Opt-Out Approach for Treating Tobacco Use Disorders." Dr. Richter received her Master of Public Health from the University […]

Drug Use in Pregnancy (ASAM FAME Session 7)

Register Now Questions about registering should be directed to: ASAM Education by email ateducation@asam.org Presenters: Abby Letcher, MD, FASAM Angela Colistra, PhD, LPC, CAADC, CCS Shanna Diaz, DO Leslie Hayes, MD Series: This 2-hour, virtual-live session is part of the FAME 8-session series and will cover overdose prevention and harm reduction. The FAME series is a facilitated, […]

Nurse Practitioners and Physician Assistants as Buprenorphine Providers: Facilitators and Barriers

This presentation will describe the expansion of nurse practitioners and other advanced practice clinicians into opioid use disorder treatment, particularly in rural communities. It will also explore barriers and facilitators regarding nurse practitioner engagement in buprenorphine treatment, including regulations, education, and broader social factors such as stigma. Specific considerations for advanced practice clinicians' work with […]

Opioid Use Disorder in Pregnant and Postpartum People: The Treatment and Policy Landscape

Register Now Presenters: Maria Manriquez, MD, FACOG, FASAM, PMH-C; Tara Sundem, APRN, NNP-BC; and Tawni Carson Sponsor: National Council for Mental Wellbeing--NCMW NOTE: The National Council for Mental Wellbeing will not be providing Continuing Medical Education for this event. Target Audience: This activity is designed for interprofessional teams, families and patients, students and educators, nurses, […]

Expanding Harm Reduction Access in the US for Rural and Other Underserved Populations

This presentation will describe research around syringe service programs and methods of harm reduction distribution. Specific considerations for reaching members of rural communities will be discussed. Learning objectives: 1. Discuss the need for novel approaches for distributing harm reduction supplies 2. Describe benefits and challenges regarding syringe service programs 3. Outline specifics of programs that […]

A Qualitative Analysis of US State Laws Regulating Incentives for Health Behavior

This presentation will describe the results of a qualitative study examining state laws regulating incentives for health behavior. Such laws may have important implications for provision of contingency management for substance use disorder, including in rural areas. Register and attend to learn more! Speaker: Barbara "Basia" Andraka-Christou, PhD, JD, Assistant Professor in the School of […]

Providing Comprehensive Care in Opioid Treatment Program: A Policy and Provider Perspective

Presenters: Mark Parrino, President and CEO of The American Association for the Treatment of Opioid Dependence, Inc. Jennifer Seib, VP of Strategic Initiatives and Integration at BestSelf Behavioral Health Sponsor: National Council for Mental Wellbeing--NCMW Credit designational available: None Target Audience: Interprofessional teams, patients, educators, nurses, physicians, psychiatrists, psychologists, executives, clinical staff, administrators and social […]

Buprenorphine in the Age of Fentanyl: Discussing the New Guidance

Presenter: John Mariani, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round table" conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. Register now

Reaching People Where They’re At: Smoking Cessation Treatment Delivery at Your Door

This presentation will discuss novel ways to deliver evidence-based treatment for smoking cessation within and across rural areas. It will focus on 4 separate clinical trials of medication sampling, each demonstrating feasibility and efficacy of a simple yet novel treatment approach to reach a broad spectrum of smokers, including those who may not yet want […]

Clinical Primer and Discussion on Weekly and Monthly Injectable Buprenorphine

Presenter: Michelle Lofwall, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round table" conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. Register now

Buprenorphine Dosing and Preparations in the Era of Fentanyl

Presenters: Gail D’Onofrio, MD and Andrew Herring, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round table" conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. Register […]

Addressing the Intersection of Pain Management and Opioid Use: Integrating Care to Promote Healthy Outcomes

This hybrid full-day training summit will explore the clinical intersection of pain and opioid use. Interdisciplinary attendees will learn about evidence-based practices (pharmacological and non) for treating these complex and often co-occurring conditions. More information In-person participation is preferred, though a virtual option is also available. This Summit will focus on addressing pain and opioid […]